- Scope of the procurement
- Lot 1 Atracurium besilate 50mg/5ml solution for injection
- Lot 10 Remifentanil 2mg powder for concentrate for solution for injection
- Lot 11 Metaraminol 10 mg/ml Solution for Injection/Infusion
- Lot 12 Magnesium sulfate 50% (magnesium 2mmol/ml) solution for injection 10ml
- Lot 2 - Meropenem 1g powder for solution for injection
- Lot 3 - Midazolam 5mg/ml Solution for Injection/Infusion 10ml (50mg/10ml)
- Lot 4 Noradrenaline (Norepinephrine) 1 mg/ml for injection 8ml (8mg/8ml)
- Lot 5 Paracetamol 10 mg/ml solution for injection 100ml (1g/100ml)
- Lot 6 Propofol 20 mg/ml Emulsion for injection 50ml (1g/50ml)
- Lot 7 Rocuronium 10 mg/ml solution for injection 5ml (50mg/5ml)
- Lot 8 Tinzaparin sodium 4,500 anti-Factor Xa IU/ml pre-filled syringe for inject
- Lot 9 Cisatracurium 5 mg/ml Solution for injection 30ml (150mg/30ml)
Section one: Contracting authority
one.1) Name and addresses
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
10 South Colonnade
London
E14 4PU
Contact
Anna Spencer
Country
United Kingdom
Region code
UKI42 - Tower Hamlets
Internet address(es)
Main address
https://www.gov.uk/government/organisations/uk-health-security-agency
Buyer's address
https://www.gov.uk/government/organisations/uk-health-security-agency
one.2) Information about joint procurement
The contract is awarded by a central purchasing body
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://health-family.force.com/s/Welcome
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be submitted to the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Supportive Medicines Stockpile
Reference number
CM/EMP/23/C225886
two.1.2) Main CPV code
- 33600000 - Pharmaceutical products
two.1.3) Type of contract
Supplies
two.1.4) Short description
The supply of Supportive Medicines for Intensive Treatment Units.
two.1.5) Estimated total value
Value excluding VAT: £1
two.1.6) Information about lots
This contract is divided into lots: Yes
Tenders may be submitted for all lots
two.2) Description
two.2.1) Title
Lot 1 Atracurium besilate 50mg/5ml solution for injection
Lot No
Lot 1
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £1
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 10 Remifentanil 2mg powder for concentrate for solution for injection
Lot No
Lot 10
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 11 Metaraminol 10 mg/ml Solution for Injection/Infusion
Lot No
Lot 11
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 12 Magnesium sulfate 50% (magnesium 2mmol/ml) solution for injection 10ml
Lot No
Lot 12
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 2 - Meropenem 1g powder for solution for injection
Lot No
Lot 2
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 3 - Midazolam 5mg/ml Solution for Injection/Infusion 10ml (50mg/10ml)
Lot No
Lot 3
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 4 Noradrenaline (Norepinephrine) 1 mg/ml for injection 8ml (8mg/8ml)
Lot No
Lot 4
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 5 Paracetamol 10 mg/ml solution for injection 100ml (1g/100ml)
Lot No
Lot 5
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 6 Propofol 20 mg/ml Emulsion for injection 50ml (1g/50ml)
Lot No
Lot 6
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 7 Rocuronium 10 mg/ml solution for injection 5ml (50mg/5ml)
Lot No
Lot 7
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 8 Tinzaparin sodium 4,500 anti-Factor Xa IU/ml pre-filled syringe for inject
Lot No
Lot 8
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Lot 9 Cisatracurium 5 mg/ml Solution for injection 30ml (150mg/30ml)
Lot No
Lot 9
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
the supply of Supportive Medicines for Intensive Treatment Units
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 February 2024
End date
31 March 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
15 January 2024
Local time
1:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 6 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
15 January 2024
Local time
1:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.3) Additional information
Responding to this notice: suppliers who do not respond to this procurement exercise in the following manner may be disqualified from the procurement process provided that the following conditions will operate in addition to and not replace any other conditions stated in the procurement documents which may result in disqualification.
1) Submission of expression of interest and procurement specific information.
This procurement exercise will be conducted on the eTendering portal at https: //health-family.force.com/s/Welcome Candidates wishing to be considered for this procurement exercise must register and provide additional procurement specific information (if requested), through the eTendering portal as follows
1.1) If not already registered, candidates should register on the eTendering portal at https://health-family.force.com/s/Welcome and click the link to register:
— ‘accept the terms and conditions’;
— enter your correct business details;
— click ‘Submit’ when complete;
— you will shortly receive an email from the Salesforce platform asking you to finalise your registration.
1.2) Once registered, candidates must express interest as follows:
(a) login to the eTendering portal;
(b) select ‘Find Opportunities’;
(c) select the opportunity that you are interested in;
(d) ‘Register interest’;
(e) select ‘confirm’;
(f) once you have expressed interest, it will move to ‘My Proposals and Quotes’, where you can download additional documentation (if required) and construct your reply as instructed.
You must then publish your reply using the ‘Publish’ button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the Atamis Help-desk at +44 800 9956035 or support-health@atamis.co.uk .
2) General supplier information.
To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Governments supplier information database, supplier registration, as follows
2.1) If not already registered, candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select ‘Register’ at the top right of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun and Bradstreet (D&B) D-U-N-S® Number to enable registration on Supplier Registration.
2.2) Once registration is complete you are able to create and update your registered company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.
2.3) For further help or information concerning supplier registration, please contact the Helpdesk at:support@nqc.com or telephone +44(0)1614137982. Documentation availability candidates are advised that the contracting authority has taken measures to protect confidential information contained within the full suite of procurement documents by restricting access to those documents. The contracting authority will only provide access to the full suite of procurement documents to candidates who satisfy the selection criteria and complete the non-disclosure agreement provided via Atamis eTendering portal in accordance with the instructions provided by the contracting authority. The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly and Scottish Ministers.
six.4) Procedures for review
six.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
Country
United Kingdom